Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 07, 2026 21:47 ET | Source: Kahn Swick & Foti, LLC

uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

uniQure (QURE) Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit
April 07, 2026 21:44 ET | Source: Kahn Swick & Foti, LLC

Gemini Space Station, Inc. Notice of May 18, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Gemini (GEMI) Investors Have Opportunity to Lead Gemini Space Station, Inc. Securities Fraud Lawsuit
April 07, 2026 21:35 ET | Source: Kahn Swick & Foti, LLC

Enphase Energy, Inc. Notice of April 20, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Enphase (ENPH) Investors Have Opportunity to Lead Enphase Energy, Inc. Securities Fraud Lawsuit
April 07, 2026 21:35 ET | Source: Kahn Swick & Foti, LLC

Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Corcept (CORT) Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit
April 07, 2026 21:33 ET | Source: Kahn Swick & Foti, LLC

Kyndryl Holdings, Inc. Notice of April 13, 2026 Application Deadline for Class Action Lawsuits - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Kyndryl (KD) Investors Have Opportunity to Lead Kyndryl Holdings, Inc. Securities Fraud Lawsuit
April 07, 2026 21:29 ET | Source: Kahn Swick & Foti, LLC

Apollo Global Management, Inc. Securities Fraud Class Action Result of Undisclosed Relationship with Jeffrey Epstein and 16% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Apollo (APO) Investors Have Opportunity to Lead Apollo Global Management, Inc. Securities Fraud Lawsuit
April 07, 2026 21:28 ET | Source: Kahn Swick & Foti, LLC

Driven Brands Holdings Inc. Securities Fraud Class Action Result of Erroneous Financial Statements and 39% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Driven Brands (DRVN) Investors Have Opportunity to Lead Driven Brands Holdings Inc. Securities Fraud Lawsuit
March 31, 2026 22:50 ET | Source: Kahn Swick & Foti, LLC

uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

uniQure (QURE) Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit
March 31, 2026 22:16 ET | Source: Kahn Swick & Foti, LLC

Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Ultragenyx (RARE) Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit
March 31, 2026 22:07 ET | Source: Kahn Swick & Foti, LLC

ImmunityBio, Inc. Securities Fraud Class Action Result of FDA Warning and 21% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

ImmunityBio (IBRX) Investors Have Opportunity to Lead ImmunityBio, Inc Securities Fraud Lawsuit